Global Viral Clearance Market Size By Method (Viral Removal, Viral Inactivation), By Application (Recombinant Proteins, Blood And Blood Products, Vaccines), By End-User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations), By Geographic Scope And Forecast

Report ID: 24294|No. of Pages: 202

product image

Global Viral Clearance Market Size By Method (Viral Removal, Viral Inactivation), By Application (Recombinant Proteins, Blood And Blood Products, Vaccines), By End-User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations), By Geographic Scope And Forecast

Report ID: 24294|Published Date: May 2024|No. of Pages: 202|Base Year for Estimate: 2023|Format:   Report available in PDF formatReport available in Excel Format

Viral Clearance Market Size And Forecast

Viral Clearance Market size was valued at USD 628.37 Million in 2024 and is projected to reach USD 1455.27 Million by 2031, growing at a CAGR of 12.21% during the forecasted period 2024 to 2031.

Viral Clearance Market is estimated to grow at a CAGR of 12.21% & reach USD 1455.27 Mn by the end of 2031

Global Viral Clearance Market Drivers

The market drivers for the Viral Clearance Market can be influenced by various factors. These may include:

  • Increasing Demand for Biopharmaceuticals: The demand for biopharmaceuticals is experiencing a concurrent increase, necessitating the implementation of rigorous viral clearance procedures to guarantee the safety of the products. Biopharmaceuticals, such as gene therapies, vaccines, and monoclonal antibodies, frequently incorporate biological substances; therefore, viral clearance is of the utmost importance in order to avert the spread of viral contaminants.
  • Strict regulatory obligations: Regulatory agencies, including the European Medicines Agency (EMA) in Europe and the Food and Drug Administration (FDA) in the United States, impose rigorous criteria for viral clearance in the manufacturing of biopharmaceuticals. Compliance with these regulations motivates the implementation of cutting-edge technologies and services for viral clearance.
  • An increasing prevalence of viral infections: The growing incidence of viral infections, including hepatitis, HIV/AIDS, and emergent viruses such as Ebola and Zika, highlights the criticality of implementing efficient viral clearance strategies. On account of this development, ongoing advancements in viral clearance technologies are required to combat the ever-changing viral threats.
  • Developments in Bioprocessing Methods: Bioprocessing technological advancements, such as methods for purification, cell culture, and analytical assays, contribute to enhanced viral clearance capabilities. These developments empower biopharmaceutical firms to improve the effectiveness and dependability of viral clearance procedures.
  • Growing Biomanufacturing Sector: Growing The demand for viral clearance solutions is fueled by the expanding biomanufacturing sector, which is propelled by the development of novel biologics and biosimilars. Consistent with the anticipated growth trajectory of the biopharmaceutical market, the viral clearance market is anticipated to experience ongoing expansion.
  • Increasing Outsourcing of Viral Clearance Services: A growing trend in the biopharmaceutical industry is the delegation of viral clearance testing and validation responsibilities to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs). In viral eradication activities, the demand for specialized knowledge, infrastructure, and cost-efficiency motivates this outsourcing trend.
  • Emergence of Novel Viral Clearance Technologies: The emergence of novel viral clearance technologies is the subject of ongoing research and development. These technologies aim to provide enhanced effectiveness, velocity, and cost-effectiveness. Market expansion is aided by innovations including chromatography techniques, viral inactivation technologies, and filtration methods of the next generation.
  • Globalization of Pharmaceutical Manufacturing: The globalization of pharmaceutical manufacturing is a significant factor in the widespread implementation of standardized viral clearance procedures in various geographic areas. Organizations that have operations in numerous nations strive to conform to global regulatory norms, which has generated significant interest in viral clearance solutions worldwide.

Global Viral Clearance Market Restraints

Several factors can act as restraints or challenges for the Viral Clearance Market. These may include:

  • Stringent Regulatory Requirements: Regulatory bodies enforce rigorous guidelines and criteria to ensure the viral clearance of biological products. This can result in extended development and approval processes, as well as increased costs.
  • High Cost of Viral Clearance Procedures: Viral clearance procedures frequently necessitate the use of sophisticated technology and apparatus, the acquisition and upkeep of which can be quite costly. Smaller organizations or corporations may be dissuaded from entering the market by the exorbitant expense.
  • Complexity of Viral Clearance Procedures: Difficulties Associated with Viral Clearance Procedures for viral clearance can be difficult and demand specialized knowledge. Organizations might encounter difficulties when attempting to devise and execute efficient viral clearance strategies.
  • Risk of Product Contamination: Notwithstanding the implementation of stringent viral clearance protocols, the potential for product contamination remains, resulting in expensive product recalls and reputational harm.
  • Scalability Constraints: Certain viral clearance methods might present challenges in accommodating the requirements of large-scale production, especially in the case of biopharmaceuticals with substantial volume of output.
  • Emerging Viral Threats: Viral eradication strategies face a challenge posed by the perpetual evolution of viruses. Emerging viruses or new viral variants may necessitate the development of novel clearance methods, thereby increasing market complexity and unpredictability.
  • Competition from Alternative Technologies: Alternative Technologies Vulnerabilities to Traditional Viral Elimination Methods may face competition from technologies such as filtration or thermal treatment that aim to inactivate or eliminate viruses.
  • Ethical and Safety Considerations: The utilization of specific viral clearance methods that incorporate potentially hazardous compounds or animal-derived products may give rise to ethical concerns.

Global Viral Clearance Market: Segmentation Analysis

The Global Viral Clearance Market is Segmented on the basis of Method, Application, End-User, And Geography.

Viral Clearance Market Segmentation Analysis

 

Viral Clearance Market, By Method

  • Viral Removal
  • Viral Inactivation

Based on the Method, The market is bifurcated into Viral Removal and Viral Inactivation. The Viral Removal segment is expected to hold the largest market share. The factors can be attributed to the high acceptance of this method, the growth of R&D activities by biopharmaceutical companies, and the accuracy, speed, & flexibility provided by the method in life sciences research.

Viral Clearance Market, By Application

  • Recombinant Proteins
  • Blood and Blood Products
  • Vaccines
  • Others

Based on the Application, The market is bifurcated into Recombinant Proteins, Blood and Blood Products, Vaccines, and Others. The other segment is predicted to hold the most significant CAGR in the forecasted period due to the growing public & private funding for stem cell research, the use of tissue-based therapies to treat various diseases, and the rising use of cellular therapies in the treatment of various disorders.

Viral Clearance Market, By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

Based on End-User, The market is bifurcated into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, and Others. The Contract Research Organizations segment is anticipated to hold the largest market share. The factors can be credited for the increasing outsourcing of Drug Discovery Services to CROs by pharmaceutical companies, academic institutes, small biotechnology companies, & start-ups and the ability of CROs to invest in extensive drug discovery infrastructure.

Viral Clearance Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Regional Analysis, The Global Viral Clearance Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America owing to growth in the pharmaceuticals industry, rising number of drug approvals, and the presence of national institutes supporting biotechnology and life science research in this region.

Key Players

  • Charles River Laboratories International
  • Merck KGaA
  • Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec)
  • Texcell
  • Kedrion
  • Bsl Bioservice
  • Vironova Biosafety
  • Clean Cells Virusure GmbH

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2021-2031

Base Year

2023

Forecast Period

2024-2031

Historical Period

2021-2023

Unit

Value (USD Million)

Key Companies Profiled

Charles River Laboratories International, Merck KGaA, Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec), Texcell, Kedrion, Bsl Bioservice, Vironova Biosafety.

Segments Covered

By Method, By Application, By End-User, And By Geography.

Customization Scope

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope.

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post sales analyst support

Customization of the Report

In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Viral Clearance Market was valued at USD 628.37 Million in 2024 and is projected to reach USD 1455.27 Million by 2031, growing at a CAGR of 12.21% during the forecasted period 2024 to 2031.

The need for Viral Clearance Market is driven by Increasing Demand for Biopharmaceuticals, Strict regulatory obligations, An increasing prevalence of viral infections and Developments in Bioprocessing Methods.

The major players are Charles River Laboratories International, Merck KGaA, Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec), Texcell, Kedrion, Bsl Bioservice, Vironova Biosafety.

The Global Viral Clearance Market is Segmented on the basis of Method, Application, End-User, And Geography.

The sample report for the Viral Clearance Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

1 INTRODUCTION OF GLOBAL VIRAL CLEARANCE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL VIRAL CLEARANCE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL VIRAL CLEARANCE MARKET, BY METHOD
5.1 Overview
5.2 Viral Removal
5.3 Viral Inactivation

6 GLOBAL VIRAL CLEARANCE MARKET, BY APPLICATION
6.1 Overview
6.2 Recombinant Proteins
6.3 Blood and Blood Products
6.4 Vaccines
6.5 Others

7 GLOBAL VIRAL CLEARANCE MARKET, BY END-USER
7.1 Overview
7.2 Pharmaceutical & Biotechnology Companies
7.3 Contract Research Organizations
7.4 Academic Research Institutes
7.5 Others

8 GLOBAL VIRAL CLEARANCE MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East and Africa

9 GLOBAL VIRAL CLEARANCE MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Charles River Laboratories International
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Merck KGaA
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec)
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Texcell
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Kedrion
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Bsl Bioservice
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Vironova Biosafety
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Clean Cells
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Virusure GmbH
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

11 Appendix
11.1 Related Research

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Viral Clearance Market

report-detail

Download Sample Report

View More Reports